2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

Leuzy, A. ; Ashton, N. J. ; Mattsson-Carlgren, N. ; Dodich, A. ; Boccardi, M. ; Corre, J. ; Drzezga, A. ; Nordberg, A. ; Ossenkoppele, R. ; Zetterberg, H. ; Blennow, K. ; Frisoni, G. B. ; Garibotto, V. ; Hansson, O.

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2121-2139 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg